Abstract Giardia duodenalis is a very common, ubiquitous, intestinal protozoan parasite infecting animals and humans. Of the eight distinct genetic assemblages known to date, assemblages A and B are infectious to humans. Giardia is the most commonly recognized cause of traveller's diarrhea. Giardiasis impairs weight gain and is responsible for a variety of extraintestinal and post-infectious complications, including postinfectious irritable bowel syndrome, chronic fatigue, failure to thrive, and cognitive impairment. Giardiasis occurs in the absence of invasion of the intestinal tissues by the trophozoites and in the absence of any overt inflammatory cell infiltration, with the exception of a modest increase in intraepithelial lymphocytes and mast cells. In endemic parts of the World where the infection is often concurrent with bacterial enteritis causing inflammation-driven diarrheal disease, giardiasis appears to be protective against diarrhea. Recent observations have demonstrated that this effect may be due to a direct immuno-modulating effect of the parasite via its cathepsin B cysteine protease which cleaves pro-inflammatory CXCL8. No known toxin has yet been directly implicated in the pathophysiology of giardiasis. Diarrhea in giardiasis is mostly malabsorptive in nature, rather than hypersecretory. Findings from ongoing research indicate that the post-infectious effects of giardiasis may be due to microbiota dysbiosis induced by the parasite during the acute phase of infection.
Introduction
Giardiasis is caused by the diplomonad protozoan Giardia duodenalis (synonymous Giardia lamblia or Giardia intestinalis). It is the most common waterborne parasitic infection of the human intestine worldwide. Due to the high burden of G. duodenalis-related illnesses in the developing world, its impairment on development and socioeconomic improvements, and its close association with poverty, this parasite has been included in the World Health Organization's (WHO) Neglected Diseases Initiative since 2006 [1•, 2, 3••] . G. duodenalis is the most commonly recognized etiologic agent of traveller's diarrhea [4] . Eight distinct genetic assemblages, "A" through "H," are known to exist for G. duodenalis thus far. Assemblages A and B are infectious to humans, while assemblage E is thought to exhibit a predilection for livestock [3••, 5, 6] . The anthropo-zoonotic potential of the parasite has been well established [7] [8] [9] [10] [11] [12] . Giardiasis may significantly impair productivity in food-producing animals [13] [14] [15] . G duodenalis has a simple life cycle, which includes the dormant infective cyst released in the feces, each producing, upon exposure to gastric juices during ingestion, one tetranucleated short-lived excyzoite, which will divide twice to give rise to four diploid trophozoites [3••] . Trophozoites are the diseasecausing stage and colonize the upper small intestine, where they adhere to the epithelial surface and proliferate by binary fission. Pathophysiology in the acute phase of giardiasis occurs in the absence of invasion of the intestinal tissues by the This article is part of the Topical Collection on Protozoa (Giardia) * Andre G. Buret aburet@ucalgary.ca trophozoites and in the absence of any overt inflammatory cell infiltration, with the exception of a modest increase in intraepithelial lymphocytes and mast cells [16, 17•] . No known toxin has yet been unequivocally implicated in the pathophysiology of giardiasis [3••, 16] . Clinical manifestations of giardiasis usually appear 1 to 2 weeks after infection and may range from asymptomatic to acute or chronic diarrhea, abdominal pain, vomiting, and weight loss [ [43] . The reduction in intestinal barrier function induced by giardiasis implicates disruptions of F-actin, zonula occludens 1 (ZO-1), claudin-1 and claudin-4, occludin, and α-actinin, the latter being a component of the actomyosin ring that regulates paracellular flow [19••, 38•, 41••, 44, 45] . Loss of epithelial barrier integrity is mediated by activation of epithelial myosin light chain kinase [46] . Disruptions of epithelial tight junctional proteins by Giardia are caspase-3-dependent, similarly to other enteric disorders [38•, 46, 47••, 48, 49] . However, recent findings also point to a direct role for cysteine proteases released by the parasite in the proteolytic disruption of epithelial villin, an important constituent of brush border microvilli [50, 51] . Remodeling of intestinal epithelial villin has also been observed during late stages of G. duodenalis infection in vivo where it occurs via CD4+ and CD8+ immune responses [52•] . Interestingly, inhibition of parasite proteases does not seem to prevent degradation of the intestinal tight junction-associated protein ZO-1, consistent with the hypothesis that G. duodenalis induces epithelial pathophysiology via multiple pathways [49] . Overall, Giardia-induced diffuse shortening of brush border microvilli causes small intestinal malabsorption due to impaired absorption of water, glucose, and electrolytes. Anion hypersecretion may further contribute to the production of the resulting diarrhea [19••, 53-55] . Recent findings indicate that the pathogenic effects of Giardia may be further compounded by degradation of local mucins by the parasite [56] , which may in turn contribute to the translocation of commensal bacteria through the epithelium [45, 56, 57, 58•] . An isolated report indicates that giardiasis may be associated with increased mucus secretion, but the biological significance of this observation has yet to be determined [27] . Recent findings indicate that G. duodenalis may cause mucin depletion in goblet cells of the small intestine, as well as in the colon [56] . These phenomena warrant further investigation. While at least some of the pathogenic effects of Giardia are isolate-dependent, the identification of a Giardia "enterotoxin" has remained elusive. Various reports from Europe, Africa, South America, Asia, and Australia have attempted to correlate parasite genotype with symptoms. Some have suggested that assemblage B may cause more severe disease in humans [21• ], but there are conflicting studies reporting otherwise, consistent with the fact that microbial, host, and environmental factors contribute to disease. These genotypic differences have raised the hitherto unsettled question of whether there are two different Giardia species [3••, 6, 9, 59, 60] . A number of these microbes, including Campylobacter jejuni, the number one cause of bacterial enteritis worldwide, are also known to predispose susceptible individuals with inflammatory bowel disease (IBD) to inflammation flare-ups and exacerbation of disease [62] . Research is warranted to assess whether Giardia may also exacerbate symptoms in patients with IBD. Long-term and extra-intestinal consequences that have been reported for giardiasis include post-infectious irri- In giardiasis and other enteric infections, severe diarrhea may lead to poor cognitive function caused by zinc and iron micronutrient deficiencies, as well as defects in the antioxidant system, which may all affect neuroplasticity [25•, 26, 65-67] . Indeed, studies conducted in Brazil and Peru observed that diarrheal disease occurring in the first 2 years of life negatively affects cognitive function, verbal fluency, and physical fitness and may lead to long-term growth faltering [68, 69] . Post-infectious wasting and/or stunting often associates with general behavioral and developmental consequences that present as failure to thrive [68, 70, 71] . Other reports found that diarrhea during early childhood can impair visual-motor coordination, auditory short-term memory, information processing, and cortical cognitive function [67, 69] . The exact biological bases of the post-infectious clinical sequelae due to Giardia, months and sometimes years after the parasite has been eliminated, remain unclear.
Post-Infectious Complications in Giardiasis
Cause-to-effect studies using models with human pathogens are needed to help characterize the mechanisms responsible for post-infectious complications following acute infection with enteropathogens. A recent study [45 unpublished] described a model of post-infectious irritable bowel syndrome in neonatal rats infected with G. duodenalis. Fifty days postinfection with G. duodenalis (Assemblage A or B), long after the parasite was cleared, rats developed visceral hypersensitivity to luminal balloon distension, activation of nociceptive signaling pathway characterized by increased c-fos expression, histological modifications (villus atrophy and crypt hyperplasia), and proliferation of intraepithelial lymphocytes and mucosal mast cells. G. duodenalis infection also disrupted intestinal barrier function, which in turn promoted the translocation of commensal bacteria, in association with the development of intestinal hypersensitivity. In that study, Giardiainduced bacterial translocation correlated with the degradation of the tight junctional proteins occludin and claudin-4. These findings clearly demonstrate that indeed, Giardia can cause post-infectious visceral hypersensitivity. Importantly, this report also shows that Giardia-induced visceral hypersensitivity may occur in the rectum, a site far remote from the site of parasitic colonization-consistent with Giardia-induced mucin depletion in the colon [56] -giving new impetus for research on the effects of giardiasis in the distal intestine.
Microbial-Microbial Interactions in the Gut and Pathogenesis of Giardiasis
Microbial-microbial interactions in the gut may play a key role in the disease outcome of giardiasis. Earlier findings have established that commensal microbiota may protect the host against Giardia [72] . Conversely, bacterial components of the microbiota from patients with symptomatic giardiasis appear to heighten G. intestinalis virulence in gnotobiotic mice, via unclear mechanisms [73] . Recent findings indicate that G. duodenalis may induce a relative expansion in the abundance of Firmicutes and the appearance of Proteobacteria groups in human gut microbiota [57 unpublished] . In that study, Giardia-modified human gut microbial communities also exhibited a significant capacity for epithelial translocation and intestinal invasion. Germ-free mice reconstituted with Giardia-treated human gut microbiota showed distinct increases in colonic pro-inflammatory mediators. These observations are consistent with the hypothesis that Giardia may cause representatives of the host commensal microbiota to become virulent. Indeed, various bacterial preparations, including human gut microbiota, induce lethal toxicity in Caenorhabditis elegans when administered concurrently with G. duodenalis [74••] . This may explain why abnormal gut permeability can persist post-infectiously in giardiasis [58•, 74••] . And when post-infectious complications persist for months, microscopic small intestinal inflammation may develop [20•, 58•, 75] . Together, these observations suggest that Giardia may increase the virulence of commensal microbiota bacteria during the acute phase of the infection. In turn, these altered microbiota will induce a host inflammatory response, which may be responsible, at least in part, for the long-term, post-infectious, complications seen in giardiasis. This topic represents an area of intense ongoing research and may help pave the way toward novel, "probiotic-like,"-based therapies.
Immuno-Modulation by Giardia and Symptom Variability
During the acute stage of the infection, Giardia trophozoite loads can exceed one million organisms per centimeter of gut, and yet, the intestinal mucosa of most Giardia-infected hosts does not exhibit any overt signs of inflammation, with the exception of a small increase in intra-epithelial lymphocytes and mucosal mast cell numbers [3••, 54, 76, 77] . Isolated reports have observed signs of microscopic duodenal inflammation in some patients infected with G. duodenalis assemblage B [76, 78] . The reasons for this surprising attenuation of host intestinal inflammation remain unclear. Giardia infections are transmitted via ingestion of infectious cysts in contaminated food or water or directly via the fecal-oral route. This route of infection is shared by a broad variety of gastrointestinal pathogens, and as a result, Giardia co-infections are not uncommon [29••] . The most commonly detected coenteropathogens include Vibrio cholera, rotavirus, norovirus, enteropathogenic E. coli, and Helicobacter pylori [79] [80] [81] . Giardia infections have also been reported to occur concurrently with Ascaris sp., Cryptosporidium sp., and Salmonella sp. [82] [83] [84] [85] [86] . Although most of these pathogens are known to promote inflammatory responses and induce diarrheal disease within their hosts, such co-infections are often asymptomatic [29••, 87] . Moreover, a recent study on Tanzanian children demonstrated that those infected with G. duodenalis had a reduced likelihood of developing diarrheal disease and fever as well as lower levels of serum C-reactive protein, a classic marker of inflammation, when compared to Giardia-negative children [25•] . These observations have prompted ongoing research into the immuno-modulating potential of Giardia.
Microarray analysis of jejunal tissues collected from G. duodenalis-infected calves has revealed decreased mRNA expression of several pro-inflammatory mediators and increased expression of anti-inflammatory factors [88] . Also, G. duodenalis may reduce host dendritic cell interleukin-12, partly via Giardia-induced arginine depletion [89•, 90] . Giardia arginine deiminase has also been shown to attenuate nitric oxide production from intestinal epithelial cells [91, 92•, 93] . Recent observations also revealed another immuno-modulatory effect by a parasite, in which assemblage A trophozoites attenuate the secretion of CXCL8 from human small intestinal mucosal biopsies administered with pro-inflammatory IL-1β or bacterial toxins and from human epithelial enterocytes administered with IL-1β or Salmonella typhimurium in vitro [29••, 87] . Further examination found that Giardia was also able to inhibit the production of a variety of pro-inflammatory mediators and chemokines in the mouse colon challenged with Clostridium difficile toxin A/B, as well as in inflamed human gut tissue biopsies from patients with Crohn's disease [29••] . This reduction of CXCL8 leads to decreased neutrophil chemotaxis and was the result of secreted G. duodenalis cathepsin B-like proteases that degraded CXCL8. The G. duodenalis genome contains genes for at least 23 cathepsin cysteine proteases, the majority of which have no described function [94, 95] . However, several G. duodenalis cathepsin proteases are upregulated upon exposure to intestinal epithelial cells [87, 96] . Even though cathepsin protease assays suggested that assemblage B G. duodenalis trophozoites secrete cysteine proteases with similar activity, these failed to degrade CXCL8, indicative of an isolate-specific effect [28•, 87] . These findings demonstrate that assemblage A G. duodenalis trophozoites possess immunomodulatory factors that may inhibit pro-inflammatory intestinal responses in infected tissues. It is well known that neutrophils induce intestinal epithelial anion hypersecretion and, consequently, water loss, and diarrhea [97, 98] . Hence, as neutrophil accumulation contributes to the development of diarrheal disease, the local release of direct immunomodulatory Giardia cathepsins may help explain the lower inflammation scores and reduced incidence of diarrhea in hosts co-infected with G. duodenalis and enteropathogens that cause diarrhea via intestinal inflammation. In host populations where co-infections with pro-inflammatory enteropathogens are less common, Giardia on its own is a cause of diarrheal disease. Whether and how Giardia's immunomodulating effects may also modify the intestinal environment to make it more favorable for colonization by other pathogens requires further investigation. More research is also needed to examine the structure and function of G. duodenalis cathepsin B-like proteases to determine if these factors exhibit unique substrate specificities and whether other proteases participate in the degradation of CXCL8 and/or other immune mediators.
Virulence Factors and Disease Pathogenesis
A true Giardia enterotoxin has yet to be identified, and attempts to ascribe symptom variability to Giardia genotypes have remained inconclusive. Proteomic analysis revealed that the breadth of repertoire of Giardia variant surface proteins is isolate-dependent [99•] . While exposure to epithelial cells does result in significant changes in Giardia trophozoite gene expression and the release of several Giardia-produced metabolic enzymes [91] , the effects of these parasite factors on the host remain largely unknown.
A few virulence factors have been suggested on the basis of their targeted effects [3••, 16] . For example, ventral adhesive disc proteins and surface lectins ensure appropriate attachment to enterocytes of the upper small intestine, while the four pairs of flagella allow for movement, and variant surface proteins help evade host IgA-directed clearance [3••, 93, 100] . Variant surface protein expression may also confer zoonotic infectivity to Giardia isolates [101] . The arginine deiminase produced by the parasite deprives intestinal epithelial cells of arginine, thereby impairing intestinal epithelial proliferation and nitric oxide production [43, 91, 92•] . Alpha-2 giardin appears to be an assemblage A-specific protein [102] , but its role in hostparasite interactions remains obscure. An unknown 58-kDa product released by Giardia trophozoites has been reported to induce anion hypersecretion and intestinal fluid accumulation by activating signal transduction pathways in host enterocytes [103] . However, parasite products directly involved in the pathogenesis of giardiasis remain largely unknown.
Cathepsin-like cysteine proteases are key components of the pathogenesis of several protozoan parasitic disorders, and the Giardia genome contains genes for 23 of those proteases [94, 95, 104, 105] . Cathepsin cysteine proteases contain an active site cysteine and histidine residue. In addition, these proteases are further subdivided into cathepsin B or cathepsin L superfamilies (reviewed in [104, 106] ). Cysteine protease activity has been reported in G. duodenalis cultures [51, 107] . However, the functions of these proteases are mostly unknown, and their role in giardiasis remains obscure. Thus far, it has been established that cathepsin-like cysteine proteases are required for trophozoite encystation and excystation [94] . Adding to recent reports that G. duodenalis cathepsin Blike cysteine proteases degrade CXCL8 and attenuate neutrophil chemotaxis [29••, 87] , recent findings also suggest a role for these proteases in the disruption of enterocytic cytoskeletal villin. More research is needed to characterize virulence factors in G. duodenalis genotypes and how these may, in turn, induce pathophysiological responses in the host intestine.
Conclusions
G. duodenalis is a cosmopolitan diarrheagenic parasite of humans and a variety of animal species. Its significant impact on human health and the livestock industry has warranted its inclusion in the World Health Organization's (WHO) Neglected Diseases Initiative. Recent observations have established that the parasite can cause post-infectious visceral hypersensitivity, adding G. duodenalis to the list of enteropathogens known to be responsible for post-infectious irritable bowel syndrome. As summarized in Fig. 1 , the mechanisms responsible for pathophysiology in giardiasis include both parasite and host immune factors, as well as Giardiainduced microbiota disruptions that may directly contribute to the post-infectious gastrointestinal disorder associated with the infection. Giardia induces enterocyte apoptosis and disrupts the epithelial barrier in myosin-light chain kinasedependent manner. In turn, CD8+ lymphocyte-dependent microvillus shortening causes maldigestion and malabsorption. Compounding these effects, Giardia may also increase chloride secretion and intestinal transit, all of which further contribute to diarrhea. Intriguingly, in developing countries, where co-infections with other enteropathogens are not uncommon, the infection may protect against pediatric diarrhea. Further research needs to determine whether symptom variability can be ascribed to the immuno-modulating capacity of Giardia cathepsin-B-like proteases. The effects of heterologous infections by different Giardia genotypes also need to be investigated. To date, little is known of the virulence factors responsible for disease. The recent demonstration that a G. duodenalis surface cathepsin B-like cysteine protease may cleave epithelial cytoskeletal villin lays the foundations toward more research into the role of Giardia proteases in pathogenesis. Together, the findings reported to date illustrate that Giardia offers a powerful model system to investigate both the mechanisms of acute infectious diarrhea, as well as the mechanisms responsible for the post-infectious sequelae of parasitic, bacterial, and viral enteritis. As such, this research will help develop a rational basis for the development of new therapeutics. Human and Animal Rights and Informed Consent Some of the studies referenced in this review article used human and animal subjects. All studies by the present authors have been performed in compliance with the Human Review Ethics Board, and human subjects provided full consent. All studies were compliant with the Animal Care Review committees at the University of Calgary and with the regulations of Canadian Council on Animal Care.
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